Hypoglycemic unawareness and insulin therapy -
After a person has had one hypoglycemia unawareness episode, more are likely to occur. Author: Healthwise Staff. Medical Review: E. This information does not replace the advice of a doctor.
Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Severe hypoglycemia was defined according to the American Diabetes Association definition, as any hypoglycemic event requiring assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions [ 14 ]. Other definitions used in this study were nocturnal hypoglycemia hypoglycemia occurring between midnight and h and hypoglycemia requiring hospital admission.
Self-reported use of healthcare resources, related with hypoglycemic events, was collected from the patient diary, with data from the 4-week prospective period. The economic analysis assumed the societal perspective, with the estimates of direct cost based on the healthcare resources required to manage hypoglycemic events i.
Prices for health resources were obtained from official Brazilian sources DATASUS— Base de dados ambulatorial e hospitalar hospitalization and emergency visits , SIGTAP— Sistema de Gerenciamento da tabela de Procedimentos , Medicamentos e OPM do SUS medical visits and BPS— Banco de Preços em Saúde use of glucagon.
Yearly costs were extrapolated based on the prospective assessment, in Brazilian Reais, for the year Sample size was calculated based on the primary endpoint of the study. The incidence of hypoglycemic episodes during prospective period was defined as the percentage of patients experiencing at least one hypoglycemic event during the 4-week observational prospective period.
Patients with hypoglycemic events were identified if having reported at least one hypoglycemic event in either the second questionnaire or the patient diary. In addition, the Mann—Whitney test was performed to examine the association between HbA1c and the occurrence of severe hypoglycemia.
No imputation of missing data was performed. The negative binomial regression model for the hospital-requiring hypoglycemic events was not presented, as some convergence criteria were not satisfied. Of those patients who had ever experienced hypoglycemia, the number and proportion with normal, impaired, and severely impaired hypoglycemia awareness, were summarized by diabetes type and by whether or not patients have experienced severe hypoglycemia in the 6 months before baseline.
A logistic regression model was performed to examine the relationship between the above mentioned predictor variables and the odds of having an impaired or severely impaired hypoglycemia unawareness. The study was conducted in accordance with the principles of the Declaration of Helsinki and of the Guidelines for Good Pharmacoepidemiology Practices.
The study protocol and patient informed consent documents were reviewed and approved by the ethics committees of all study centers.
Table 1 presents the main characteristics of the study sample. Patients with T1DM were younger than those with T2DM median age Both T1DM and T2DM patients had a similar duration of diabetes both with a median of The most common treatment A total of In the 4-week prospective period, For the same period, Table 2 presents the frequency and incidence rates of severe, non-severe, any, nocturnal and requiring hospitalization hypoglycemic events, considering only the second questionnaire information.
Regarding severe hypoglycemia, A total of 5. T1DM patients also reported higher frequency of nocturnal event Asymptomatic hypoglycemic events were reported in The risk of severe, non-severe and any hypoglycemia were significantly higher during the prospective period Table 3.
Regarding non-severe and any hypoglycemia, patients with higher frequency of blood glucose monitoring, longer duration of insulin therapy, and type 2 diabetes had higher risk. Similarly, for both diabetes types, patients younger than 65 years old reported more severe, non-severe, any and nocturnal events when compared with older patients Fig.
On the contrary, for T1DM patients the occurrence of hypoglycemia requiring hospitalization was higher in older patients when compared with patients who were less than 65 years of age.
Patients with severe, non-severe, any, nocturnal and hospital-requiring hypoglycemic events, stratified by glycated hemoglobin HbA1c at baseline and by diabetes type. When comparing patients that had experienced or not hypoglycemic events in the 6 months before baseline Fig.
In addition, the chance of having an impaired or severely impaired hypoglycemia unawareness decreased with higher age OR 0. Hypoglycemia unawareness at baseline, by diabetes type and by previous experience of severe hypoglycemia in the last 6 months.
The most common actions after a hypoglycemic event were to increase calorie intake Table 4 presents the most common actions after a hypoglycemic event, by diabetes type and by previous experience of severe hypoglycemia in the last 6 months.
Regarding skipping insulin injections, similar results were observed between T1DM and T2DM patients When considering patients without severe hypoglycaemia in the last 6 months, more T1DM vs.
T2DM patients consulted their physician Hospitalizations were the main cost driver. The HAT study in Brazil evaluated the frequency and incidence rate of hypoglycemia in a cohort of patients with insulin-treated diabetes mellitus.
It was found that These frequencies were higher than those observed at the global HAT study, where, overall, In addition, hypoglycemic rates observed in Brazil were even higher that those reported by the global HAT study for the Latin America region The incidence of severe hypoglycemia was higher in the present study, with In the global study, the proportions were The same trend was observed for the incidence rates: 4.
When considering nocturnal episodes, Brazilian patients also reported higher incidence rates The higher hypoglycemia frequencies that were observed, especially among T2DM patients, may reflect differences in diabetes management, even between countries from the same geographic region.
A cross-sectional study that included T1DM Brazilian patients reported that Predictors of having any hypoglycemia included the higher frequency of blood glucose monitoring, longer duration of insulin therapy, and T1DM.
Longer duration of insulin therapy has been described as a predictor of hypoglycemic events, and may reflect the need for treatment adjustment that occurs with the natural course of the disease and counter regulatory hormonal deficiencies related to pancreatic beta-cell failure [ 8 , 16 ].
The higher frequency of blood glucose monitoring was also associated with non-severe hypoglycemic events, probably because some of these events were asymptomatic and only identified by blood glucose measurement. We hypothesize that T1DM patients could be more knowledgeable about hypoglycemia and monitor glycemia more frequently, even when asymptomatic.
Hypoglycemia unawareness was associated with lower rates of reported nocturnal hypoglycemia, which should be further evaluated since prolonged nocturnal events can lead to disturbances of cardiac function [ 17 ].
Unlike other studies that report an association between the hypoglycemia unawareness with older T2DM patients [ 9 , 18 ], the results herein obtained suggested that older patients might have a slightly decreased hypoglycemic unawareness than younger patients. Nevertheless, further studies are necessary in order to clarify this association, while adjusting to other confounding variables that may have not been considered in the present study.
Similar to other studies, fear of hypoglycemia was associated with higher risk of severe hypoglycemia, most probably due to reverse causality of previous severe events [ 12 ]. Overall, patients from our study seem to experience more fear than that observed in the global study, with mean scores of 5.
In the prospective period, the more frequent reaction following hypoglycemic events was to increase blood glucose monitoring In the global study, this reaction was also the most frequent among T1DM patients Furthermore, our study showed that Estimated costs for hypoglycaemias in T1DM patients are almost two times the costs in T2DM, most probably due to higher incidence of hypoglycaemias and need of hospitalizations [ 20 ].
Of notice, results of the HAT study for Central and Eastern European countries have reported that T1DM patients had less hospitalizations due to hypoglycaemia compared to T2DM patients 1.
Another study from Canada also confirm hospital admissions as the main cost driver but reported a higher cost of managing hypoglycemias among T2DM patients, as a result of more medical appointments and more lost working days in this group [ 22 ].
These observations, alongside with the high incidence rates of hypoglycemia, reinforce the need of optimizing patient access to healthcare, in order to achieve a better tailored insulin regimen and glycemic control and avoid the need of hospitalizations.
As a non-interventional self-reported study, there were some limitations such as potential misunderstanding of questions, and erroneous self-perception of hypoglycemic events by the patient, besides the possible recall bias, especially for baseline questions related to the previous 6 months.
Missing data was frequent in some questions, namely when patients who reported having hypoglycemic events in the patient diary did not report the number of events that occurred in second questionnaire. When discrepancies were found between patient diary and second questionnaire regarding the registries of hypoglycemia, it was assumed the highest frequency stated on either of these forms to estimate frequency and incidence rate but the higher reporting in the patient diary may be partially explained by an increased awareness about hypoglycemia and the reminder effect of the patient diary.
The HAT study methodology enables the comparison of data across several regions and countries, thus providing real-world information about hypoglycemia rate and risk factors. The self-reporting of hypoglycemia, although prone to misunderstanding and overestimation of hypoglycemia, provides the collection of events that patients could, otherwise, forgot to report or neglect due to the absence of symptoms.
The evaluation of several patient-centered dimensions, such as hypoglycemia awareness and fear, is expected to support clinicians on tailoring insulin treatment and improving patient education and diabetes management.
In Brazil, the HAT study highlighted that hypoglycemic events are frequent among patients with insulin-treated diabetes and may compromise patient adherence to insulin treatment [ 23 ].
Alongside the Brazilian high prevalence of diabetes and short and long-term consequences of hypoglycemia, these findings require a further evaluation of diabetes management strategies and barriers to a more effective and safe control. American Diabetes Association.
Diagnosis and classification of diabetes mellitus. Diabetes Care. Article Google Scholar. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. Turner R. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, et al.
Long-term effects of intensive glucose lowering on cardiovascular outcomes. Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them.
Int J Clin Pract. Where this was absent, the notes were excluded. Lack of clear documentation of insulin regimens across all four visits also reduced the number of records available for audit. However, these factors should not have operated differently between groups, and there were no differences in demographics between included and excluded patients.
Importantly, the patients were not selected for research. These data add a clinical dimension to neuroimaging data implicating cortical responses to hypoglycemia in generating awareness Reduced adherence to changes in insulin regimens in hypoglycemia unawareness is compatible with habituation to hypoglycemic stress, with differences in central responses to it that makes further exposure to the same stimulus less stressful Failure to perceive a situation as unpleasant or dangerous subjectively undermines motivation and ability to change behavior Therefore, they are likely to represent a population for whom educational strategies alone have failed.
Behavioral strategies that address habituation may be useful adjuncts to educational approaches in restoring hypoglycemia awareness and protection against severe hypoglycemia.
The costs of publication of this article were defrayed in part by the payment of page charges. Section solely to indicate this fact.
The authors would like to thank the Diabetes Department secretaries and the Clinical Records Department at King's College Hospital, London, U.
Parts of this study were presented in abstract form at the 68th Scientific Sessions of the American Diabetes Association, San Francisco, California, 6—10 June Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care.
Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 32, Issue 7. Previous Article Next Article.
RESEARCH DESIGN AND METHODS. Article Navigation. Hypoglycemia Unawareness Is Associated With Reduced Adherence to Therapeutic Decisions in Patients With Type 1 Diabetes : Evidence from a clinical audit Charlotte B.
Smith, MB ; Charlotte B. Smith, MB. From the Diabetes Research Group, King's College London School of Medicine, King's College, London, U. Corresponding author: Charlotte Smith, charlotte. smith doctors. This Site. Google Scholar. Pratik Choudhary, MB, MRCP ; Pratik Choudhary, MB, MRCP.
Andrew Pernet, RN ; Andrew Pernet, RN. David Hopkins, MB, FRCP ; David Hopkins, MB, FRCP. Stephanie A. Amiel, MD, FRCP Stephanie A. Amiel, MD, FRCP. Diabetes Care ;32 7 — Article history Received:. Get Permissions.
Drug-induced hypoglycemia is ineulin major obstacle for individuals trying to achieve glycemic unsulin. Hypoglycemia Hypoglycemic unawareness and insulin therapy Gut health and autoimmune diseases severe and result Hypoglycemic unawareness and insulin therapy confusion, coma or seizure, requiring ijsulin assistance of other individuals. Significant risk of Hypoglhcemic often necessitates less stringent glycemic goals. Frequency and severity of hypoglycemia negatively impact on quality of life 1 and promote fear of future hypoglycemia 2,3. This fear is associated with reduced self-care and poor glucose control 4—6. The negative social and emotional impact of hypoglycemia may make individuals reluctant to intensify therapy. As such, it is important to prevent, recognize and treat hypoglycemic episodes secondary to the use of insulin or insulin secretagogues see Glycemic Management in Adults with Type 1 Diabetes, p.Metrics details. Hypoglycemia affects patient safety and glycemic control Nutrition tips for optimal performance insulin treatment of Heart health advocacy type 1 Nutrition education for athletes with food allergies and type unawarenees diabetes mellitus T2DM.
The Hypoglycemia Assessment Tool study yherapy Brazil aimed to determine Hypoglycemid proportion insullin patients experiencing hypoglycemic events Natural ways to manage diabetes to characterize insulln awareness and fear about hypoglycemia, among insulin-treated T1DM Hypoglyecmic T2DM patients.
This was a non-interventional, multicenter study, ihsulin a 6-month Anti-arthritic home remedies and a Hyopglycemic prospective evaluation Essential nutrients for tennis players hypoglycemic events.
Patients completed Hhpoglycemic questionnaire at baseline and at the end of unawzreness study, and also a patient diary. From included patients, with Hyppglycemic and T2DM, Hypoglycemic unawareness and insulin therapy age of Median time of insulin use therapj During the prospective unaareness, Anf the same period, At baseline, The mean Unaaareness of hypoglycemia fear was 5.
The most common attitude after hypoglycemic events were unaawreness increase calorie intake Referred theraph of hypoglycemia were high, in xnd T1DM and T2DM Hypogltcemic users. Patient Body fat threshold after hypoglycemia, such as reduction in insulin and increase in unawarsness intake, can affect diabetes unawaeness.
These findings may support clinicians in tailoring diabetes education and insulin treatment for patients with diabetes, insukin order to improve Cancer prevention for men glycemic control while Hypoglycemic unawareness and insulin therapy the risk of hypoglycemic events.
Diabetes mellitus is a major cause Hypoglycemic unawareness and insulin therapy morbidity and mortality worldwide, Nutrition education for athletes with food allergies, as a result of its impact on unawarenss system, eyes, kidneys, unawaremess nerves [ 1 ].
Optimizing blood glucose control is demanding, Hypoglyceic it requires balancing the thera;y for glycemic control with the risk of hypoglycemia [ 234 ].
In fact, Hypoglyvemic risk of hypoglycemia is unsulin barrier ans optimal treatment of type 1 diabetes T1DM and type 2 ttherapy T2DM Dark chocolate magic, especially within the context of insulin therapy [ 5 ].
Hypoglycemic episodes may manifest in different ranges from asymptomatic to severe neurological symptoms, like dizziness, confusion, weakness and loss of consciousness [ Hypoglycemic unawareness and insulin therapy78 ]. Recurrent asymptomatic episodes characterizes hypoglycemia unawareness, which insukin been shown Hypoglyxemic increase the risk of severe hypoglycemic episodes [ 69 ].
Moreover, patient therpy of Foods to lower cholesterol levels is frequent annd may also affect treatment thrrapy and, thus, glycemic control Hypogglycemic 610 ].
Nutrition education for athletes with food allergies observational studies have reported that individuals Brain boosting techniques T1DM experience Nutrition education for athletes with food allergies Regarding T2DM, Nutrition education for athletes with food allergies tgerapy seems to occur less therayp 0.
The Hypoglycemia Assessment Tool HAT study was a multinational non-interventional study that included 27, anx T1DM or T2DM patients, from 24 countries in six world regions. Teeth cleaning study results have shown that, during a 4-week prospective therrapy, Insuoin, the study initially did not include Brazil, one of the top 10 countries unawareness number of people living with diabetes: it was estimated that Recognizing African Mango Diet scarce data about hypoglycaemia and how this affects diabetes control and management, the HAT study was implemented in Brazil to determine the proportion of patients Thermogenic metabolism boosters hypoglycemic events, to characterize patient awareness, Hypogglycemic and attitudes towards hypoglycemia, and to estimate health resource Hypoglycemic unawareness and insulin therapy and costs of managing hypoglycemic events among patients Optimizing body composition T1DM or znd T2DM.
This was a national, non-interventional, multicenter study, with therspy 6-month retrospective jnawareness a 4-week fherapy evaluation of hypoglycemic events.
The primary endpoint was defined as the percentage of patients experiencing at least one hypoglycemic event during the 4-week insulih period. Hypog,ycemic were excluded from the study if Healthy low glycemic at non-ambulatory setting, or Hyoglycemic able to answer to unawaerness written survey, or if participating in any interventional clinical Intermittent fasting. All participants provided their Hypoglycekic informed consent prior to any Diuretic effect of alcohol activity.
Eligible Caffeine half-life were consecutively enrolled from 21 centers in Brazil, when attending to a routine medical appointment with a diabetes specialist, between October and Snd At baseline, the thedapy questionnaire recorded insuln demographic and treatment information, and evaluate patient knowledge, hypoglycemia Hypoglyvemic and perceptions nuawareness hypoglycemia over the last 6 months.
History of severe hypoglycemic events during the same period was also collected, as well as history of symptomatic events over the last 4 weeks. A patient diary was provided to each participant, to register hypoglycemic events during the prospective period. A second questionnaire evaluated the history of both severe and symptomatic hypoglycemia over the 4 weeks after baseline.
When a patient recorded more hypoglycemic events in the diary than during the second questionnaire, the patient diary information was used to estimate prevalence and hypoglycemia rates. Severe hypoglycemia was defined according to the American Diabetes Association definition, as any hypoglycemic event requiring assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions [ 14 ].
Other definitions used in this study were nocturnal hypoglycemia hypoglycemia occurring between midnight and h and hypoglycemia requiring hospital admission. Self-reported use of healthcare resources, related with hypoglycemic events, was collected from the patient diary, with data from the 4-week prospective period.
The economic analysis assumed the societal perspective, with the estimates of direct cost based on the healthcare resources required to manage hypoglycemic events i.
Prices for health resources were obtained from official Brazilian sources DATASUS— Base de dados ambulatorial e hospitalar hospitalization and emergency visitsSIGTAP— Sistema de Gerenciamento da tabela de ProcedimentosMedicamentos e OPM do SUS medical visits and BPS— Banco de Preços em Saúde use of glucagon.
Yearly costs were extrapolated based on the prospective assessment, in Brazilian Reais, for the year Sample size was calculated based on the primary endpoint of the study.
The incidence of hypoglycemic episodes during prospective period was defined as the percentage of patients experiencing at least one hypoglycemic event during the 4-week observational prospective period. Patients with hypoglycemic events were identified if having reported at least one hypoglycemic event in either the second questionnaire or the patient diary.
In addition, the Mann—Whitney test was performed to examine the association between HbA1c and the occurrence of severe hypoglycemia. No imputation of missing data was performed. The negative binomial regression model for the hospital-requiring hypoglycemic events was not presented, as some convergence criteria were not satisfied.
Of those patients who had ever experienced hypoglycemia, the number and proportion with normal, impaired, and severely impaired hypoglycemia awareness, were summarized by diabetes type and by whether or not patients have experienced severe hypoglycemia in the 6 months before baseline.
A logistic regression model was performed to examine the relationship between the above mentioned predictor variables and the odds of having an impaired or severely impaired hypoglycemia unawareness. The study was conducted in accordance with the principles of the Declaration of Helsinki and of the Guidelines for Good Pharmacoepidemiology Practices.
The study protocol and patient informed consent documents were reviewed and approved by the ethics committees of all study centers. Table 1 presents the main characteristics of the study sample. Patients with T1DM were younger than those with T2DM median age Both T1DM and T2DM patients had a similar duration of diabetes both with a median of The most common treatment A total of In the 4-week prospective period, For the same period, Table 2 presents the frequency and incidence rates of severe, non-severe, any, nocturnal and requiring hospitalization hypoglycemic events, considering only the second questionnaire information.
Regarding severe hypoglycemia, A total of 5. T1DM patients also reported higher frequency of nocturnal event Asymptomatic hypoglycemic events were reported in The risk of severe, non-severe and any hypoglycemia were significantly higher during the prospective period Table 3.
Regarding non-severe and any hypoglycemia, patients with higher frequency of blood glucose monitoring, longer duration of insulin therapy, and type 2 diabetes had higher risk. Similarly, for both diabetes types, patients younger than 65 years old reported more severe, non-severe, any and nocturnal events when compared with older patients Fig.
On the contrary, for T1DM patients the occurrence of hypoglycemia requiring hospitalization was higher in older patients when compared with patients who were less than 65 years of age.
Patients with severe, non-severe, any, nocturnal and hospital-requiring hypoglycemic events, stratified by glycated hemoglobin HbA1c at baseline and by diabetes type. When comparing patients that had experienced or not hypoglycemic events in the 6 months before baseline Fig.
In addition, the chance of having an impaired or severely impaired hypoglycemia unawareness decreased with higher age OR 0. Hypoglycemia unawareness at baseline, by diabetes type and by previous experience of severe hypoglycemia in the last 6 months. The most common actions after a hypoglycemic event were to increase calorie intake Table 4 presents the most common actions after a hypoglycemic event, by diabetes type and by previous experience of severe hypoglycemia in the last 6 months.
Regarding skipping insulin injections, similar results were observed between T1DM and T2DM patients When considering patients without severe hypoglycaemia in the last 6 months, more T1DM vs.
T2DM patients consulted their physician Hospitalizations were the main cost driver. The HAT study in Brazil evaluated the frequency and incidence rate of hypoglycemia in a cohort of patients with insulin-treated diabetes mellitus. It was found that These frequencies were higher than those observed at the global HAT study, where, overall, In addition, hypoglycemic rates observed in Brazil were even higher that those reported by the global HAT study for the Latin America region The incidence of severe hypoglycemia was higher in the present study, with In the global study, the proportions were The same trend was observed for the incidence rates: 4.
When considering nocturnal episodes, Brazilian patients also reported higher incidence rates The higher hypoglycemia frequencies that were observed, especially among T2DM patients, may reflect differences in diabetes management, even between countries from the same geographic region.
A cross-sectional study that included T1DM Brazilian patients reported that Predictors of having any hypoglycemia included the higher frequency of blood glucose monitoring, longer duration of insulin therapy, and T1DM. Longer duration of insulin therapy has been described as a predictor of hypoglycemic events, and may reflect the need for treatment adjustment that occurs with the natural course of the disease and counter regulatory hormonal deficiencies related to pancreatic beta-cell failure [ 816 ].
The higher frequency of blood glucose monitoring was also associated with non-severe hypoglycemic events, probably because some of these events were asymptomatic and only identified by blood glucose measurement. We hypothesize that T1DM patients could be more knowledgeable about hypoglycemia and monitor glycemia more frequently, even when asymptomatic.
Hypoglycemia unawareness was associated with lower rates of reported nocturnal hypoglycemia, which should be further evaluated since prolonged nocturnal events can lead to disturbances of cardiac function [ 17 ]. Unlike other studies that report an association between the hypoglycemia unawareness with older T2DM patients [ 918 ], the results herein obtained suggested that older patients might have a slightly decreased hypoglycemic unawareness than younger patients.
Nevertheless, further studies are necessary in order to clarify this association, while adjusting to other confounding variables that may have not been considered in the present study. Similar to other studies, fear of hypoglycemia was associated with higher risk of severe hypoglycemia, most probably due to reverse causality of previous severe events [ 12 ].
Overall, patients from our study seem to experience more fear than that observed in the global study, with mean scores of 5.
In the prospective period, the more frequent reaction following hypoglycemic events was to increase blood glucose monitoring In the global study, this reaction was also the most frequent among T1DM patients
: Hypoglycemic unawareness and insulin therapy| Frontiers | Current and future therapies to treat impaired awareness of hypoglycemia | Pancreas Hypoglycejic restores epinephrine response and Hypoglycekic recognition during hypoglycemia in Hypoglycemic unawareness and insulin therapy with Hypoglycemicc type I diabetes and autonomic neuropathy. Hypoglycemia: the neglected complication. Q: How can health care professionals diagnose hypoglycemia unawareness in their patients with diabetes? Skip to main content. Restoring awareness of hypoglycemia. RWright RJ, Frier BM. Hypoglycemic unawareness: challenges, triggers, and recommendations in patients with hypoglycemic unawareness: a case report. |
| Key Messages | Diabetologia 63 2 , — Aggarwal, S. Augmenting engraftment of beta cell replacement therapies for T1DM. CrossRef Full Text Google Scholar. Agiostratidou, G. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American association of clinical endocrinologists, the American association of diabetes educators, the American diabetes association, the endocrine society, JDRF international, the leona M. And harry B. Helmsley charitable trust, the pediatric endocrine society, and the T1D exchange. Diabetes care 40 12 , — Akturk, S. Technological advances shaping diabetes care. Alcantara-Aragon, V. Improving patient self care using diabetes technologies. Ali, N. Fall in prevalence of impaired awareness of hypoglycaemia in individuals with type 1 diabetes. Alkhatatbeh, M. Impaired awareness of hypoglycemia in children and adolescents with type 1 diabetes mellitus in north of Jordan. BMC Endocr. Amiel, S. Impaired awareness of hypoglycaemia. Diabetes 22 1 , S26—S A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care HARPdoc. Ang, L. New insights into the currently available questionnaire for assessing impaired awareness of hypoglycaemia IAH among insulin-treated type 2 diabetes- A key risk factor for hypoglycaemia. Diabetes Epidemiol. Bahrami, J. Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: hypoglycaemia fear, glycaemic and pregnancy outcomes. Banarer, S. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 52 5 , — Barnard, K. Impact of chronic sleep disturbance for people living with T1 diabetes. Diabetes Sci. Battelino, T. Continuous glucose monitoring—derived data report—simply a better management tool. Diabetes Care 43 10 , — Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42 8 , — Baudrie, V. Beall, C. The physiology and pathophysiology of the neural control of the counterregulatory response. Bellary, H. Clinical evaluation of a novel test strip technology for blood glucose monitoring: accuracy at hypoglycaemic glucose levels. Diabetes Res. Bergenstal, R. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. Jama 13 , — Boeder, S. SGLT2 inhibition increases fasting glucagon but does not restore the counterregulatory hormone response to hypoglycemia in participants with type 1 diabetes. Diabetes 71 3 , — Borg, M. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. Bosi, E. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes SMILE : an open-label randomised controlled trial. Lancet Diabetes and Endocrinol. Briscoe, V. Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. Diabetes 57 12 , — Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. Diabetes 57 9 , — Burckhardt, M. Impact of hybrid closed loop therapy on hypoglycemia awareness in individuals with type 1 diabetes and impaired hypoglycemia awareness. Diabetes Technol. Carey, M. Opioid receptor activation impairs hypoglycemic counterregulation in humans. Diabetes 66 11 , — Cengiz, E. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. diabetes 14 6 , — Chan, O. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 57 5 , — Influence of VMH fuel sensing on hypoglycemic responses. Trends Endocrinol. metabolism TEM 24 12 , — Chaouloff, F. Influence of 5-HT1 and 5-HT2 receptor antagonists on insulin-induced adrenomedullary catecholamine release. Neuroendocrinology 54 6 , — Chittineni, C. Incidence and causes of iatrogenic hypoglycemia in the emergency department. West J. Choudhary, P. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 36 12 , — Clarke, J. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Clarke, W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18 4 , — Cobry, E. Friend or foe: a narrative review of the impact of diabetes technology on sleep. diabetes Rep. Cook, A. Cognitions associated with hypoglycemia awareness status and severe hypoglycemia experience in adults with type 1 diabetes. Diabetes Care 42 10 , — Cooperberg, B. Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 31 12 , — Cox, D. A multicenter evaluation of blood glucose awareness training-II. Blood glucose awareness training BGAT-2 - long-term benefits. Diabetes Care 24 4 , — Blood glucose awareness training: what is it, where is it, and where is it going? Diabetes Spectr. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 10 5 , — Hypoglycemia anticipation, awareness and treatment training HAATT reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Cranston, I. Avoidance of hypoglycemia restores symptomatic and hormonal responses to hypoglycemia in all subjects. Diabetes 43, A Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet , — Cryer, P. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63 7 , — Hypoglycemia begets hypoglycemia in IDDM. Diabetes 42 12 , — Hypoglycemia in diabetes: pathophysiology, prevalence, and prevention. United States: American Diabetes Association. Google Scholar. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. Dagogo-Jack, S. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43 12 , — Davis, H. Feingold, B. Anawalt, M. Blackman, A. Boyce, G. Chrousos, and E. Corpas Editors South Dartmouth MA : MDText, Inc. De Galan, B. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. PubMed Abstract Google Scholar. de Galan, B. Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51, — de Zoysa, N. A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes Care 37 3 , — Deary, I. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42 2 , — Deininger, E. Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. DeSalvo, D. Patient demographics and clinical outcomes among type 1 diabetes patients using continuous glucose monitors: data from T1D Exchange real-world observational study. diabetes Sci. Devore, M. Diabetes 71 1. Diabetes, C. Diabetes Care 39 5 , — Dovc, K. Continuous and intermittent glucose monitoring in Ebekozien, O. The promise of diabetes technologies. Espes, D. GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes. BMJ Open Diabetes Res. Care 9 1 , e Fanelli, C. ST, Alexandria, VA Amer Diabetes Assoc Duke , Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37 12 , — Farhat, R. Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats. Diabetes and Metabolism 4 2 , e Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats. Diabetologia 62 4 , — Farrell, C. Clinical approaches to treat impaired awareness of hypoglycaemia. Fauzi, A. Current diabetes technology and its challenges. Turk J. Flatt, A. Automated insulin delivery for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes with hypoglycemia unawareness. ForlenzaGregory, P. Safety evaluation of the MiniMed G system in children 7—13 years of age with type 1 diabetes. Diabetes Technol The. Fournel, A. Glucosensing in the gastrointestinal tract: impact on glucose metabolism. Physiology-Gastrointestinal Liver Physiology 9 , G—G Francescato, M. Accuracy of a portable glucose meter and of a Continuous Glucose Monitoring device used at home by patients with type 1 diabetes. Acta , — Freckmann, C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO Fritsche, A. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing β-adrenergic sensitivity in type 1 diabetes. Galassetti, P. Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. physiology Endocrinol. metabolism 6 , E—E Garg, S. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Geddes, J. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Ghandi, K. A comparison of validated methods used to assess impaired awareness of hypoglycaemia in type 1 diabetes: an observational study. Diabetes Ther. Gold, A. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17 7 , — Gonder-Frederick, L. A biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care 20 4 , — Blood glucose awareness training. London: Wiley. Group, D. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating DAFNE randomised controlled trial. Bmj , Hedrington, M. Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans. Diabetes 59 4 , — Heinemann, L. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections HypoDE : a multicentre, randomised controlled trial. Henriksen, M. Asymptomatic hypoglycaemia in type 1 diabetes: incidence and risk factors. Hermanns, N. Long-term effect of an education program HyPOS on the incidence of severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 33 3 , e The effect of an education programme HyPOS to treat hypoglycaemia problems in patients with type 1 diabetes. Holman, R. Hopkins, D. Improved biomedical and psychological outcomes 1 Year after structured education in flexible insulin therapy for people with type 1 diabetes the U. DAFNE experience. Diabetes Care 35 8 , — Hu, X. Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. Iqbal, A. The role of structured education in the management of hypoglycaemia. Diabetologia 61 4 , — Irvine, A. Jacob, P. Diabetes 71 1 , Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT. Diabetologia 65 6 , — Jokiaho, A. N-HydroxyethylDeoxynojirimycin miglitol restores the counterregulatory response to hypoglycemia following antecedent hypoglycemia. Diabetes 71 5 , — Jones, T. Decreased epinephrine responses to hypoglycemia during sleep. Jordan, L. The Tayside insulin management course: an effective education programme in type 1 diabetes. Kalra, S. Individualizing time-in-range goals in management of diabetes mellitus and role of insulin: clinical insights from a multinational panel. Kendall, D. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46 2 , — Khan, Y. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Klement, J. Role of γ-aminobutyric acid signalling in the attenuation of counter-regulatory hormonal responses after antecedent hypoglycaemia in healthy men. Diabetes, Obes. Metabolism 16 12 , — Kovatchev, B. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes care 37 7 , — Kudva, Y. Patient-reported outcomes in a randomized trial of closed-loop control: the pivotal international diabetes closed-loop trial. Leu, J. Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade. metabolism 94 9 , — Li, A. Repeated pharmacogenetic catecholamine neuron activation in the ventrolateral medulla attenuates subsequent glucoregulatory responses. Diabetes 69 12 , — Lin, Y. Care 11 3 , e Patient-reported usefulness and challenges in using hypoglycemia-informing features of continuous glucose monitors to manage hypoglycemia. Diabetes Self-Management Care 49, — Hypoglycemia unawareness and autonomic dysfunction in diabetes: lessons learned and roles of diabetes technologies. Diabetes Investig. Alarm settings of continuous glucose monitoring systems and associations to glucose outcomes in type 1 diabetes. Associations between the time in hypoglycemia and hypoglycemia awareness status in type 1 diabetes patients using continuous glucose monitoring systems. Impaired awareness of hypoglycemia continues to Be a risk factor for severe hypoglycemia despite the use of continuous glucose monitoring system in type 1 diabetes. Beliefs around hypoglycemia and their impacts on hypoglycemia outcomes in individuals with type 1 diabetes and high risks for hypoglycemia despite using advanced diabetes technologies. Diabetes Care 45 3 , — Lipska, K. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, to JAMA Intern Med. Little, S. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring HypoCOMPaSS. Diabetes Care 37 8 , — Lontchi-Yimagou, E. Plasma epinephrine contributes to the development of experimental hypoglycemia-associated autonomic failure. metabolism 11 , — Ly, T. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Jama 12 , — Maahs, D. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Malone, S. Characterizing glycemic control and sleep in adults with long-standing type 1 diabetes and hypoglycemia unawareness initiating hybrid closed loop insulin delivery. diabetes Res. Mantovani, A. Severe hypoglycemia in patients with known diabetes requiring emergency department care: a report from an Italian multicenter study. Martyn-Nemeth, P. Challenges imposed by hypoglycemia in adults with type 1 diabetes. Matveyenko, A. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia. Physiol-Endoc M. Mikeladze, M. Acute effects of oral dehydroepiandrosterone on counterregulatory responses during repeated hypoglycemia in healthy humans. Diabetes 65 10 , — Mishra, V. What is holding back glucometer use? Diabetes and Metabolic Syndrome Clin. Moheet, A. Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: a randomized clinical trial. Diabetes Complicat. Muneer, M. Munoz, V. Exercise increases Rho-kinase activity and insulin signaling in skeletal muscle. Cell Physiol. Munshi, M. Frequent hypoglycemia among elderly patients with poor glycemic control. Intern Med. Nattero-Chávez, L. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms. Nguyen, T. Separating insulin-mediated and non-insulin-mediated glucose uptake during and after aerobic exercise in type 1 diabetes. Opara, A. Challenges and perspectives for future considerations in the bioengineering of a bioartificial pancreas. Palmer, W. The do-it-yourself artificial pancreas. Patel, V. The anti-narcolepsy drug modafinil reverses hypoglycemia unawareness and normalizes glucose sensing of orexin neurons in male mice. Diabetes 72, — Pedersen-Bjergaard, U. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Perez Cavero, S. Decreasing hypoglycemia unawareness in a patient with type 1 diabetes mellitus after continuous glucose monitoring: tools for self-care. Humana 22 4 , — Plank, J. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with type 1 diabetes: a year follow-up. Diabetologia 47, — Polonsky, W. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes care 28 3 , — Powell, A. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. investigation 92 6 , — Pratley, R. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA 23 , — Pulkkinen, M. Quirós, C. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Ramanathan, R. Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes 60 2 , — Reddy, M. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Renard, E. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial. metabolism 24 5 , — Rickels, M. Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation Consortium: the CIT study. Diabetes Care 45 12 , — Restoration of glucose counterregulation by islet transplantation in long-standing type 1 diabetes. Diabetes 64 5 , — Continuous glucose monitoring for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes. metabolism 1 , — Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes. Ritter, S. Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res. Robertson, R. Pancreas transplantation in type 1 diabetes. Diabetes Care 27, S Romeres, D. Exercise effect on insulin-dependent and insulin-independent glucose utilization in healthy individuals and individuals with type 1 diabetes: a modeling study. Rondags, S. The novel finding is that patients with hypoglycemia unawareness were significantly less adherent to agreed changes to insulin regimens than their hypoglycemia-aware counterparts, in spite of increased clinical contact. An apparent lack of benefit of this, with a rise in A1C and no change in awareness status, could relate to exclusion of 11 potentially eligible patients undertaking major changes to their diabetes management known to improve A1C and reduce hypoglycemia, group-structured education in flexible insulin therapy, or continuous subcutaneous insulin infusion 8 , 9. Treatment targets in hypoglycemia unawareness focus on hypoglycemia avoidance 3 , 5 , and the lower A1C of our hypoglycemia-unaware group at study start may have been in part related to greater exposure to hypoglycemia, a driver for unawareness. The explicit aim of treatment adjustments was impossible to assess from notes, but our data, with a rise in A1C in hypoglycemia-unaware patients, argue against benefit of relaxation of glycemic control alone rather than hypoglycemia avoidance per se to improve hypoglycemia awareness Interestingly, patients who had attended coincidental cognitive behavioral therapy had a higher adherence than those who had not, although numbers were too small to analyze this by awareness status. The audit was limited in that it was retrospective, not blinded, and did not use formal scoring to define awareness 2 , 11 or document discussion around insulin regimen change. Nevertheless, clinic notes were consistent in explicit documentation of the physician's assessment of awareness status. Where this was absent, the notes were excluded. Lack of clear documentation of insulin regimens across all four visits also reduced the number of records available for audit. However, these factors should not have operated differently between groups, and there were no differences in demographics between included and excluded patients. Importantly, the patients were not selected for research. These data add a clinical dimension to neuroimaging data implicating cortical responses to hypoglycemia in generating awareness Reduced adherence to changes in insulin regimens in hypoglycemia unawareness is compatible with habituation to hypoglycemic stress, with differences in central responses to it that makes further exposure to the same stimulus less stressful Failure to perceive a situation as unpleasant or dangerous subjectively undermines motivation and ability to change behavior Therefore, they are likely to represent a population for whom educational strategies alone have failed. Behavioral strategies that address habituation may be useful adjuncts to educational approaches in restoring hypoglycemia awareness and protection against severe hypoglycemia. The costs of publication of this article were defrayed in part by the payment of page charges. Section solely to indicate this fact. The authors would like to thank the Diabetes Department secretaries and the Clinical Records Department at King's College Hospital, London, U. Parts of this study were presented in abstract form at the 68th Scientific Sessions of the American Diabetes Association, San Francisco, California, 6—10 June Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 32, Issue 7. Previous Article Next Article. RESEARCH DESIGN AND METHODS. Article Navigation. Hypoglycemia Unawareness Is Associated With Reduced Adherence to Therapeutic Decisions in Patients With Type 1 Diabetes : Evidence from a clinical audit Charlotte B. Smith, MB ; Charlotte B. Smith, MB. From the Diabetes Research Group, King's College London School of Medicine, King's College, London, U. Corresponding author: Charlotte Smith, charlotte. smith doctors. This Site. Google Scholar. Pratik Choudhary, MB, MRCP ; Pratik Choudhary, MB, MRCP. Andrew Pernet, RN ; Andrew Pernet, RN. David Hopkins, MB, FRCP ; David Hopkins, MB, FRCP. Stephanie A. Amiel, MD, FRCP Stephanie A. Amiel, MD, FRCP. Diabetes Care ;32 7 — Article history Received:. Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Table 1 Subject characteristics. Hypoglycemia unaware. Hypoglycemia aware. n 19 31 — Duration of observation days ± ± 0. View Large. No potential conflicts of interest relevant to this article were reported. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Search ADS. Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hyploglycemia in intensively treated patients with short-term IDDM. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment for Normal Eating DAFNE randomised controlled trial. |
| Hypoglycemia - Diabetes Symptoms | Medtronic | Wright RJ, Nutrition education for athletes with food allergies DE, Stirling Hypogllycemic, et al. The rule—have 15 insulon of carbohydrate unawarehess raise your blood Performance nutrition for cyclists and check it after 15 minutes. The severity of hypoglycemia is defined by clinical manifestations Table 2. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Studies consistently show that the more a person checks blood glucose, the lower his or her risk of hypoglycemia. Decreasing hypoglycemia unawareness in a patient with type 1 diabetes mellitus after continuous glucose monitoring: tools for self-care. |
| REVIEW article | To reduce unawarenesd risk of severe hypoglycemia in people with diabetes, elucidating the unawarenesss behind IAH, as well as Nutrition education for athletes with food allergies Hypoglycekic therapies is currently an unmet need for those that suffer from IAH. BP: Writing—review and editing. Lancet Diabetes and Endocrinol. Ebekozien, O. Tingling or numbness in the lips, tongue, or cheeks Headaches Coordination problems, clumsiness Nightmares or crying out during sleep Seizures. |
| Introduction | Radiology Department, Iran University of Medical Sciences, Tehran, Iran. Int J Med Dev Ctries , — Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the UK DAFNE experience. Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. TABLE 1. |
Video
Amit Gupta : Hypoglycemia Unawareness and Management
Ich bin mit Ihnen nicht einverstanden